Dopamine Agonist — Transdermal Patch (Parkinson's / RLS)
Pregnancy: Avoid — limited data
Rotigotine
Brand names: Neupro
Adult dose
Dose: Parkinson's (early): start 2 mg/24h, titrate weekly by 2 mg/24h to max 8 mg/24h; Parkinson's (advanced): max 16 mg/24h; RLS: 1–3 mg/24h
Route: Transdermal patch (apply once daily, rotate sites)
Frequency: Once daily (change patch every 24 hours)
Max: 16 mg/24h (Parkinson's); 3 mg/24h (RLS)
Only transdermal dopamine agonist — provides continuous drug delivery avoiding peaks and troughs associated with oral agents. Particularly useful when oral route unavailable (nil by mouth, dysphagia). Rotate patch sites — abdomen, thigh, hip, flank, upper arm, shoulder.
Paediatric dose
Route:
Seek specialist opinion — not licensed in children.
Dose adjustments
Renal
No dose adjustment required.
Hepatic
Caution in severe hepatic impairment.
Clinical pearls
- CRITICAL: remove patch before MRI — aluminium backing causes burns. The patient must be reminded at every MRI appointment.
- ICD screening at every visit — same risks as oral dopamine agonists (QUIP questionnaire)
- Continuous delivery advantage: avoids pulsatile dopamine stimulation — theoretically reduces dyskinesia development. Useful in patients with significant wearing-off on oral regimens.
Contraindications
- MRI or cardioversion — remove patch before procedure (contains aluminium in backing layer)
- Hypersensitivity to rotigotine
Side effects
- Application site reactions (erythema, pruritus, oedema)
- Impulse control disorders (ICD — gambling, hypersexuality)
- Somnolence and sudden sleep onset
- Nausea
- Hallucinations
- Peripheral oedema
Interactions
- Antipsychotics (dopamine antagonism)
- Metoclopramide (dopamine antagonism)
- Other dopaminergic agents (additive effects)
Monitoring
- ICD screening (QUIP)
- Application site rotation and skin reactions
- Blood pressure (postural)
- Sleep assessment
Reference: BNFc; BNF 90; NICE NG71 (Parkinson's Disease); MHRA ICD Warning. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Acute Stroke / TIA Assessment · NICE NG128; RCP Stroke Guidelines 2023
- Status Epilepticus (Adults) · NICE CG137; ESEM guidelines; RCP Neurology Guidelines
- Suspected Subarachnoid Haemorrhage · NICE NG228; RCEM 2023; AHA/ASA 2023
- Adult Head Injury · NICE NG232 (2023)
- Bell's Palsy / Facial Nerve Palsy · ENT UK 2017; AAN
- Vertigo Workup · ENT UK; NICE CKS